ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
ASLAN presents Ph2 study data for Varlitinib tested on BTC patients
September 20, 2019Enrolment in a global pivotal study of varlitinib in second line BTC, the TreeTopp (TREatmEnT OPPortunity) study, was completed ahead of schedule in December 2018 and topline data is expected in the second half of 2019. -
Abstract on Ph2 study of Varlitinib gets acceptance for oral prentation at CSCP 2019
August 28, 2019New data from Aslan’s study of Varlitinib in patients with advanced or metastatic biliary tract cancer will be presented at upcoming 2019 Chinese Society of Clinical Oncology (CSCO) annual meeting; a largest clinical trial conducted to date on biliary tra
Pharma Sources Insight January 2025
